|
Sign In to gain access to subscriptions and/or personal tools.
|
Effects of enalapril or nifedipine on muscle strength or functional capacity in elderly subjects. A double blind trial
Daniel Bunout
Institute of Nutrition and Food Technology (INTA), University of Chile, Santiago, Chile, dbunout{at}inta.cl
Gladys Barrera
Institute of Nutrition and Food Technology (INTA), University of Chile, Santiago, Chile
María Pía de la Maza
Institute of Nutrition and Food Technology (INTA), University of Chile, Santiago, Chile
Laura Leiva
Institute of Nutrition and Food Technology (INTA), University of Chile, Santiago, Chile
Claudia Backhouse
Department of Medicine, Central Campus Faculty of Medicine, University of Chile, Santiago, Chile
Sandra Hirsch
Institute of Nutrition and Food Technology (INTA), University of Chile, Santiago, Chile
Introduction. The inhibition of angiotensin-converting enzyme could be useful to avoid sarcopenia in the elderly.
Materials and methods. We compared in a prospective double blind trial, the effects of treatment with enalapril or nifedipine on muscle performance in hypertensive elderly subjects. Patients were followed for nine months, and at baseline, 4.5 months and the end of follow-up, quadriceps and hand grip muscle strength, walking capacity, timed up and go and the short physical performance test were measured. Results. During follow-up, more subjects on nifedipine than on enalapril discontinued the medication due to side-effects. No differences in the evolution of muscle strength, walking capacity or functional measures were observed. At nine months, plasma angiotensin-converting enzyme activity decreased by 6.0±2.5 U/L among patients on enalapril and increased by 8.5±4.2 U/L (p<0.001) among patients on nifedipine.
Conclusion. In this group of elderly subjects, enalapril was not superior to nifedipine with regard to the age-related decline of muscle performance.
Key Words: enalapril muscle strength nifedipine sarcopenia
References
- Newman AB, Kupelian V., Visser M. et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci 2006;61:72-7.[Web of Science][Medline]
[Order article via Infotrieve]
- Bunout D., de la Maza MP, Barrera G., Leiva L., Gattas V., Hirsch S. Assessment of sarcopenia: longitudinal versus cross sectional body composition data. Aging Clin Exp Res 2007; 19:295-9.[Web of Science][Medline]
[Order article via Infotrieve]
- Bunout D., Barrera G., Avendano M. et al. Results of a community-based weight-bearing resistance training programme for healthy Chilean elderly subjects. Age Ageing 2005;34:80-3.[Free Full Text]
- Garg R., Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 1995;273:1450-6.[Abstract/Free Full Text]
- Onder G., Penninx BW, Balkrishnan R. et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet 2002;359:926-30.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Montgomery H., Clarkson P., Barnard M. et al. Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet 1999;353:541-5.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Strazzullo P., Iacone R., Iacoviello L. et al. Olivetti Prospective Heart Study. Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study. Ann Intern Med 2003;138:17-23.[Abstract/Free Full Text]
- Schellenbaum GD, Smith NL, Heckbert SR et al. Weight loss, muscle strength, and angiotensin-converting enzyme inhibitors in older adults with congestive heart failure or hypertension. J Am Geriatr Soc 2005;53:1996-2000.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Maggio M., Ceda GP, Lauretani F. et al. Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study). Am J Cardiol 2006;97:1525-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Han Y., Runge MS, Brasier AR Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. Circ Res 1999;84:695-703.[Abstract/Free Full Text]
- Yamaguchi K., Ura N., Murakami H. et al. Olmesartan ameliorates insulin sensitivity by modulating tumor necrosis factor-alpha and cyclic AMP in skeletal muscle. Hypertens Res 2005;28:701-02.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Carter CS, Onder G., Kritchevsky SB, Pahor M. Angiotensin-converting enzyme inhibition intervention in elderly persons: effects on body composition and physical performance. J Gerontol A Biol Sci Med Sci 2005;60:1437-46.[Web of Science][Medline]
[Order article via Infotrieve]
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). NIH Publication No. 04-5230, 2003.
- Folstein MF, Folstein SE, McHugh PR "Mini mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-98.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Bunout D., Barrera G., Leiva L. et al. Effects of vitamin D supplementation and exercise training on physical performance in Chilean vitamin D deficient elderly subjects. Exp Gerontol 2006;41:746-52.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- McGavin CR, Gupta SP, McHardy GJ Twelve-minute walking test for assessing disability in chronic bronchitis. Br Med J 1976;1:822-3.[Abstract/Free Full Text]
- Rockwood K., Awalt E., Carver D., MacKnight C. Feasibility and measurement properties of the functional reach and the timed up and go tests in the Canadian study of health and aging. J Gerontol A Biol Sci Med Sci 2000;55:M70-3.[Web of Science][Medline]
[Order article via Infotrieve]
- Guralnik JM, Ferrucci L., Pieper CF et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci 1995;55:M221-31.
- Lindpaintner K., Pfeffer MA, Kreutz R. et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-11.[Abstract/Free Full Text]
- Neels HM, van Sande ME, Scharpé SL Sensitive colorimetric assay for angiotensin converting enzyme in serum. Clin Chem 1983;29:1399-403.[Abstract/Free Full Text]
- Dyckner T., Wester PO Plasma and skeletal muscle electrolytes in patients on long-term diuretic therapy for arterial hypertension and/or congestive heart failure. Acta Med Scand 1987;222:231-6.[Web of Science][Medline]
[Order article via Infotrieve]
- Beckett NS, Peters R., Fletcher AE et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-98.[Abstract/Free Full Text]
- Fogari R., Zoppi A. Effect of antihypertensive agents on quality of life in the elderly. Drugs Aging 2004;21:377-93.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sumukadas D., Witham MD, Struthers AD, McMurdo ME Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial. CMAJ 2007;177:867-74.[Abstract/Free Full Text]
- Minami N., Li Y., Guo Q. et al. Effects of angiotensin-converting enzyme inhibitor and exercise training on exercise capacity and skeletal muscle. J Hypertens 2007;25:1241-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Rouyer O., Zoll J., Daussin F. et al. Effect of angiotensin-converting enzyme inhibition on skeletal muscle oxidative function and exercise capacity in streptozotocin-induced diabetic rats. Exp Physiol 2007;92:1047-56.[Abstract/Free Full Text]
- Charbonneau DE, Hanson ED, Ludlow AT et al. ACE genotype and the muscle hypertrophic and strength responses to strength training. Med Sci Sports Exerc 2008;40:677-83.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Bunout B., Barrera G., de la Maza P. et al. Effects of nutritional supplementation and resistance training on muscle strength in free living elders. Results of one year follow. J Nutr Health Aging 2004;8:68-75.
- Kannus P., Sievänen H., Palvanen M., Järvinen T., Parkkari J. Prevention of falls and consequent injuries in elderly people. Lancet 2005;366:1885-93.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Gillespie LD, Gillespie WJ, Robertson MC, Lamb SE, Cumming RG, Rowe BH Interventions for preventing falls in elderly people. Cochrane Database Syst Rev 2003; 4:CD000340.[Medline]
[Order article via Infotrieve]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 10, No. 2,
77-84 (2009)
DOI: 10.1177/1470320309105338

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|